TDAC - Translational Devel... Stock Analysis | Stock Taper
Logo
Translational Development Acquisition Corp.

TDAC

Translational Development Acquisition Corp. NASDAQ
$10.54 -0.09% (-0.01)

Market Cap $231.34 M
52w High $10.56
52w Low $10.03
P/E 47.91
Volume 30
Outstanding Shares 21.91M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $137.68K $4.28M $1.66M 1.21K% $0.08 $-213.66K
Q2-2025 $191.76K $221.13K $1.62M 846.54% $0.07 $-221.13K
Q1-2025 $223.85K $347.41K $1.48M 662.53% $0.37 $-347.41K
Q4-2024 $0 $133.39K $-8.04K 0% $-0 $-135.07K
Q3-2024 $0 $61.28K $-61.28K 0% $-0.02 $-61.28K

What's going well?

Net income and EPS are up slightly, and there is no interest or tax burden this quarter. The company is still posting a profit on paper.

What's concerning?

Revenue dropped sharply, costs are out of control, and the core business is losing money. Profits are only coming from unusual, non-operating items, not from selling products or services.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $47.15K $179.98M $6.46M $173.52M
Q2-2025 $35.26K $178.18M $6.32M $171.86M
Q1-2025 $206.6K $176.6M $6.36M $170.24M
Q4-2024 $438.17K $175M $6.25M $168.75M
Q3-2024 $224.04K $393.77K $964.4K $-570.63K

What's financially strong about this company?

The company has almost no debt and a very large equity cushion. Most of its assets are long-term investments, and it paid down nearly all its debt this quarter.

What are the financial risks or weaknesses?

Cash on hand is extremely low compared to bills due soon, and current assets can't cover current liabilities. The company also has negative retained earnings and rising intangible assets, which could be risky if those values are overstated.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $1.66M $-1.24M $-2.1M $8.58M $11.89K $-1.24M
Q2-2025 $1.62M $-171.34K $0 $0 $-171.34K $-171.34K
Q1-2025 $1.48M $924.9K $-1.25M $697.02K $400.64K $-231.57K
Q4-2024 $-8.04K $-810.96K $-174.22M $175.25M $214.14K $-810.96K
Q3-2024 $-61.28K $-40.48K $0 $192.5K $152.02K $-40.48K

What's strong about this company's cash flow?

The company can still access outside funding and is returning cash to shareholders through dividends. Working capital changes provided a small temporary cash boost.

What are the cash flow concerns?

Cash burn is rising fast, and dividends are being paid with borrowed money, not profits. The company has almost no cash left and is highly dependent on new financing.

5-Year Trend Analysis

A comprehensive look at Translational Development Acquisition Corp.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

TDAC has transitioned from a small, loss-making shell into a large, revenue-generating entity on paper, with strong gross margins and a much healthier equity and liquidity profile. The sponsor team brings sector and financial expertise, and the company has demonstrated an ability to raise substantial capital and execute a transformative transaction. Short-term solvency appears comfortable, giving management some breathing room to refine operations and integrate the acquired business.

! Risks

Key risks center on quality and sustainability. The balance sheet is dominated by goodwill and other intangibles, leaving it exposed to future write-downs if performance disappoints. Cash flows from operations and free cash flow are deeply negative, indicating that the business is not yet self-funding and remains dependent on external capital. Reported debt levels are very large and financing structures complex. On top of this, limited transparency about the underlying operating business makes it difficult to assess competitive dynamics, regulatory exposure, and true economic strength.

Outlook

The outlook is highly transitional and uncertain. If the acquired business can validate the strong gross margins with consistent cash generation, demonstrate a defensible position in its end markets, and gradually reduce reliance on external financing, TDAC’s financial profile could improve significantly over time. Conversely, if revenue proves less durable than it appears, cash burn continues, or the intangibles on the balance sheet prove overly optimistic, the company could face pressure on both earnings and equity. Future disclosures about the target business, its strategy, and its cash generation will largely determine how the story develops from here.